首页> 美国政府科技报告 >Investigating Steroid Receptor Coactivator 3 (SRC3) as a Potential Therapeutic Target for Treating Advanced Prostate Cancer.
【24h】

Investigating Steroid Receptor Coactivator 3 (SRC3) as a Potential Therapeutic Target for Treating Advanced Prostate Cancer.

机译:研究类固醇受体辅激活因子3(sRC3)作为治疗晚期前列腺癌的潜在治疗靶点。

获取原文

摘要

Steroid Receptor Coactivator-3 (SRC-3) is a transcriptional coactivator that promotes proliferation of prostate cancer (CaP) cells. Although SRC-3 is highly expressed in advanced CaP, its role in PTEN deficiency- promoted castration resistant CaP (CRPC) i

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号